(Q40478040)

20 September 2017

Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies. (English)

1 reference

20 September 2017

M von Lilienfeld-Toal

1

1 reference

20 September 2017

A Schneider

2

1 reference

20 September 2017

K Orlopp

3

1 reference

20 September 2017

C Hahn-Ast

4

1 reference

20 September 2017

A Glasmacher

5

1 reference

20 September 2017

F Stüber

6

1 reference

20 September 2017

30 May 2006

1 reference

Supportive Care in Cancer

20 September 2017

1 reference

20 September 2017

14

1 reference

20 September 2017

12

1 reference

20 September 2017

1241-1245

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-006-0081-2

20 September 2017

0 references

cites work

Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia

1 reference

12 December 2020

Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation.

1 reference

12 December 2020

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

1 reference

12 December 2020

Change in serum procalcitonin (DeltaPct) predicts the clinical outcome of children admitted with febrile neutropenia

1 reference

12 December 2020

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

12 December 2020

Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults

1 reference

12 December 2020

Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score

1 reference

12 December 2020

Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

1 reference

12 December 2020

Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study

1 reference

12 December 2020

Infections in the neutropenic patient--new views of an old problem

1 reference

12 December 2020

Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients

1 reference

12 December 2020

C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients

1 reference

12 December 2020

Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia

1 reference

12 December 2020

Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia

1 reference

12 December 2020

Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia

1 reference

12 December 2020

Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation

1 reference

12 December 2020

Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8.

1 reference

12 December 2020

Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.

1 reference

12 December 2020

Procalcitonin concentrations in patients with neutropenic fever

1 reference

12 December 2020

Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein

1 reference

12 December 2020

Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits

1 reference

12 December 2020

10.1007/S00520-006-0081-2

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference